From the latest clinical trial results to the newest therapies finding their way to the clinic, the SABCS 2022 scientific program showcases the most important and most impactful clinical advances in breast cancer treatment.

Patient advocate and SABCS Program Planning Committee member Thelma Brown, BSc, talks about what she’s looking forward to at SABCS 2022 and why you will not want to miss this year’s meeting.

Regular abstract submission has closed, but there is still time to submit late-breaking abstracts for consideration. The deadline to submit a late-breaking abstract is September 30.